Matthew Bouley Upgraded (TMHC) to Hold and Increased Target to $20 on, May 13th, 2019
Matthew has made no other calls on TMHC in the last 4 months.
There are 3 other peers that have a rating on TMHC. Out of the 3 peers that are also analyzing TMHC, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Alex Rygiel of "B. Riley Securities" Maintained at Hold with Increased Target to $21 on, Thursday, February 14th, 2019
- Stephen East of "Wells Fargo" Downgraded from Buy to Hold and Held Target at $22 on, Monday, January 14th, 2019
This is the rating of the analyst that currently disagrees with Matthew
- Michael Rehaut of "JP Morgan" Upgraded from Hold to Buy on, Thursday, March 7th, 2019
on: Wed, Apr 24th 2019
by: WOPRAI
on: Wed, Apr 24th 2019
by: WOPRAI
Ross Sandler Maintained (SNAP) at Buy with Increased Target to $14 on, Apr 24th, 2019
on: Wed, Apr 24th 2019
by: WOPRAI
Eric Sheridan Maintained (SNAP) at Strong Sell with Increased Target to $8 on, Apr 24th, 2019
on: Wed, Apr 24th 2019
by: WOPRAI
Brian Nowak Maintained (SNAP) at Sell with Increased Target to $9 on, Apr 24th, 2019
on: Wed, Apr 24th 2019
by: WOPRAI
on: Thu, Apr 18th 2019
by: WOPRAI
Michael Pachter Downgraded (SNAP) to Hold on, Apr 18th, 2019
on: Thu, Mar 07th 2019
by: WOPRAI
on: Thu, Feb 14th 2019
by: WOPRAI
Alex Rygiel Maintained (TMHC) at Hold with Increased Target to $21 on, Feb 14th, 2019
on: Mon, Jan 14th 2019
by: WOPRAI
Stephen East Downgraded (TMHC) to Hold and Held Target at $22 on, Jan 14th, 2019
on: Fri, Nov 02nd 2018
by: WOPRAI
Stephen East Maintained (TMHC) at Buy with Decreased Target to $24 on, Nov 2nd, 2018
on: Mon, Mar 26th 2018
by: WOPRAI
Matthew Bouley Maintained (TMHC) at Hold with Decreased Target to $25 on, Mar 26th, 2018
on: Fri, Feb 23rd 2018
by: WOPRAI
Nishu Sood Maintained (TMHC) at Strong Buy with Increased Target to $28 on, Feb 23rd, 2018